NO933146D0 - Fremgangsmaate ved undersoekelse av lupus antikoagulerende middel - Google Patents

Fremgangsmaate ved undersoekelse av lupus antikoagulerende middel

Info

Publication number
NO933146D0
NO933146D0 NO933146A NO933146A NO933146D0 NO 933146 D0 NO933146 D0 NO 933146D0 NO 933146 A NO933146 A NO 933146A NO 933146 A NO933146 A NO 933146A NO 933146 D0 NO933146 D0 NO 933146D0
Authority
NO
Norway
Prior art keywords
lupus
investigation
procedure
anticoagulating agent
anticoagulating
Prior art date
Application number
NO933146A
Other languages
English (en)
Other versions
NO933146L (no
Inventor
Douglas A Triplett
Kurt Stocker
Original Assignee
Pentapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm Ag filed Critical Pentapharm Ag
Publication of NO933146D0 publication Critical patent/NO933146D0/no
Publication of NO933146L publication Critical patent/NO933146L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6418—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals from snakes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/4633—Snake venom from Echis carinatus; Ecarin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/4646—Snake venom from Oxyuran(eo)us scutellatus (Taipan snake of Elapidae family)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO933146A 1992-09-04 1993-09-03 Fremgangsmåte ved undersökelse av Lupus antikoagulerende middel NO933146L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92810679A EP0585504A1 (en) 1992-09-04 1992-09-04 Phospholipid dependant prothrombin activator and its use in lupus anticoagulant testing

Publications (2)

Publication Number Publication Date
NO933146D0 true NO933146D0 (no) 1993-09-03
NO933146L NO933146L (no) 1994-03-07

Family

ID=8211978

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933146A NO933146L (no) 1992-09-04 1993-09-03 Fremgangsmåte ved undersökelse av Lupus antikoagulerende middel

Country Status (5)

Country Link
US (3) US5453370A (no)
EP (1) EP0585504A1 (no)
JP (1) JPH06199673A (no)
CA (1) CA2105213A1 (no)
NO (1) NO933146L (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE267250T1 (de) * 1995-03-03 2004-06-15 Eisai Co Ltd Prothrombin aktivierendes enzym, das kalzium benötigt
US5763403A (en) * 1995-10-31 1998-06-09 Eric Chun-Tet Lian Snake venom lupus anticoagulant protein
US5766869A (en) * 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
US5925319A (en) * 1996-04-30 1999-07-20 Medtronic, Inc. Test cartridge for evaluating blood platelet functionality
US6489451B1 (en) 1997-04-10 2002-12-03 Hefei-Siu-Fung Ustc Pharmaceutical Co., Ltd. Antithrombosis enzyme from the snake venom of agkistrodon acutus
DE19734648A1 (de) * 1997-08-11 1999-02-18 Dade Behring Marburg Gmbh Verwendung von Annexinen als Lupus Antikoagulans Kontrolle oder Standard in Gerinnungstesten
AUPP345098A0 (en) * 1998-05-11 1998-06-04 National Institute Of Biological Standards And Control, United Kingdom Novel anti-fibrinolytic agents
US6165795A (en) * 1998-06-25 2000-12-26 Cardiovascular Diagnostics, Inc. Methods for performing fibrinogen assays using dry chemical reagents containing ecarin and magnetic particles
US5935802A (en) * 1998-08-10 1999-08-10 Evanston Northwestern Healthcare Research Institute Method of assaying a blood sample for prothrombin
AUPP971299A0 (en) 1999-04-12 1999-05-06 South Eastern Sydney Area Health Service Procoagulant assay
JP4102062B2 (ja) * 2001-12-19 2008-06-18 野村化学株式会社 アルミニウム測定方法
US20040091952A1 (en) * 2002-07-25 2004-05-13 Sysmex Corporation Reagent kit for detecting lupus anticoagulant
US7205153B2 (en) * 2003-04-11 2007-04-17 Applied Materials, Inc. Analytical reagent for acid copper sulfate solutions
US7727736B2 (en) * 2003-09-22 2010-06-01 The University Of North Carolina At Chapel Hill Soluble phospholipids for use in clotting factor assays
ATE395603T1 (de) * 2004-02-06 2008-05-15 Sysmex Corp Reagenziensatz zum nachweis von lupus- antikoagulant.
CN107870246B (zh) * 2010-09-20 2021-04-09 Q-塞拉有限公司 血清制备
FR2967781B1 (fr) * 2010-11-18 2019-06-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Determination du pouvoir thrombogene d'immunoglobulines humaines
US10786553B2 (en) * 2014-10-23 2020-09-29 Q-Sera Pty Ltd. Clotting composition
JP6499488B2 (ja) * 2015-03-31 2019-04-10 学校法人東日本学園 凝固時間の測定方法、ループスアンチコアグラントの存否の判定方法及びループスアンチコアグラント検出用試薬キット
CN105353141B (zh) * 2015-11-17 2018-04-10 北京美创新跃医疗器械有限公司 检测试剂及其应用及含有该试剂的试剂盒
CN117825681A (zh) * 2023-12-26 2024-04-05 米度医疗科技（中山）有限公司 一种狼疮抗凝物全液体试剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4106992A (en) * 1971-09-24 1978-08-15 Choay S.A. Purification of urokinase
CH626917A5 (no) * 1976-08-17 1981-12-15 Pentapharm Ag
US4610879A (en) * 1984-01-06 1986-09-09 University Of Southern California Fibrinolytic enzyme from snake vernom
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
US5260060A (en) * 1991-08-09 1993-11-09 University Of Southern California Fibrinolytic enzymes
US5219995A (en) * 1992-07-14 1993-06-15 Alpha Therapeutic Corporation Plasma fraction purification
US5763403A (en) * 1995-10-31 1998-06-09 Eric Chun-Tet Lian Snake venom lupus anticoagulant protein

Also Published As

Publication number Publication date
AU669550B2 (en) 1996-06-13
NO933146L (no) 1994-03-07
CA2105213A1 (en) 1994-03-05
US5453370A (en) 1995-09-26
US5922587A (en) 1999-07-13
AU4608793A (en) 1994-03-10
US5705198A (en) 1998-01-06
JPH06199673A (ja) 1994-07-19
EP0585504A1 (en) 1994-03-09

Similar Documents

Publication Publication Date Title
NO933146D0 (no) Fremgangsmaate ved undersoekelse av lupus antikoagulerende middel
NO302278B1 (no) Fremgangsmåte ved separasjon av ilmenitt
NO912330D0 (no) Fremgangsmaate ved undersoekelse av stenproever.
NO833850L (no) Fremgangsmaate ved destruksjon av oppsop
FI945441A (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
NO960179D0 (no) Anvendelse av indenoindolforbindelser
NO921028D0 (no) Fremgangsmaate ved regenerering av hydroformylerings-katalysator
AU4095278A (en) Removal of contaminants from polymer suspensions
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
NO905414L (no) Fremgangsmaate ved sammenfoeying av trematerialer.
NO933057D0 (no) Fremgangsmaate til regenerering av en alkyleringskatalysator
NO914810D0 (no) Fremgangsmaate ved fremstilling av halogenerte porfyriner
NO905453D0 (no) Fremgangsmaate ved fremstilling av klordioksyd.
KR950700738A (ko) 당뇨병 치료를 위한 퀴놀린-3-카르복시아미드 화합물의 용도(the use of quinoline-3-carboxamide compounds for treatment of diabetes)
NO920983L (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
NO934505D0 (no) Fremgangsmaate for fremstilling av en organisk vaeske
NO894039L (no) Fremgangsmaate ved fremstilling av svovelopploesningsmiddel.
NO930470D0 (no) Framgangsmaate for framstilling av ferrosilisum-legering
NO930223D0 (no) Fremgangsmaate ved fremstilling av 4,6-dialkoksypyrimidiner
NO922561D0 (no) Fremgangsmaate ved opplagring av tunge konstruksjonsdeler
NO930436L (no) Fremgangsmåte ved fremstilling av baderom
NO921011D0 (no) Fremgangsmaate for fjerning av belegg og middel for fremgangsmaatens utfoerelse
NO174249C (no) Fremgangsmåte ved enkelthudbygging av fartöy
DK376687D0 (da) Methylenchloridbaseret middel til anvendelse ved affedtning af metaller
NO933264D0 (no) Framgangsmaate for framstilling av ferrosilisium

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application